{
    "Trade/Device Name(s)": [
        "HemosIL LA Positive Control",
        "HemosIL LA Negative Control"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K102552",
    "Predicate Device Reference 510(k) Number(s)": [
        "K935254"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN",
        "GIZ",
        "GGC"
    ],
    "Summary Letter Date": "March 29, 2011",
    "Summary Letter Received Date": "March 30, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Lupus Anticoagulant"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Platelet-poor plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family",
        "ACL ELITE",
        "ELITE PRO",
        "ACL 8",
        "ACL 9",
        "ACL 10000",
        "ACL Futura",
        "ACL Advance",
        "ACL Classic (100-7000)",
        "ACL 3000",
        "ACL 6000",
        "ACL 300+"
    ],
    "Method(s)/Technology(ies)": [
        "Lyophilized preparation",
        "Quality control assessment"
    ],
    "Methodologies": [
        "Clotting time measurement"
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL LA Positive and Negative Controls for quality control of Lupus Anticoagulant assays on IL Coagulation Systems",
    "Indications for Use Summary": "For use as LA Positive and Negative Quality Controls of Lupus Anticoagulant assays (HemosIL LAC Screen/Confirm; HemosIL Silica Clotting Time) on IL Coagulation systems to assess the precision and accuracy of Lupus Anticoagulant tests",
    "fda_folder": "Hematology"
}